Lowering cancer risk and finding cancer earlier
Program 60: Cancer Risk, Prevention, and Early Detection
Researchers in Boston are working to prevent cancer and detect it earlier for people in the general population as well as those at higher risk.
Quick facts
| Grant type | P30 center grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11322566 on NIH RePORTER |
What this research studies
This program brings together scientists and clinicians across Dana‑Farber and partner hospitals to stop cancer at its earliest stages and to catch it sooner. Teams combine laboratory biology, population studies, new technologies like AI, and implementation research to turn discoveries into practical care. Work spans the general public, high-risk groups, and people with pre-cancerous changes or targetable mutations. The program also trains new researchers to help move promising tools into community use.
Who could benefit from this research
Good fit: People interested in prevention or early-detection efforts—especially those with higher genetic or clinical risk or with pre-cancerous lesions—would be most relevant to this work.
Not a fit: People with widely metastatic or late-stage cancers are unlikely to receive direct benefit from prevention and early-detection efforts.
Why it matters
Potential benefit: If successful, this work could lead to earlier cancer detection and new prevention strategies that lower cancer cases and save lives.
How similar studies have performed: Established screening programs have reduced deaths for some cancers, but integrating biomarkers, AI, and community implementation represents a newer, evolving approach.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Syngal, Sapna — Dana-Farber Cancer Inst
- Study coordinator: Syngal, Sapna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.